MedPath

Effect of PESF on speedskaters.

Not yet recruiting
Conditions
Sporters, AthletesSchaatsers, SpeedskatersSchaatsen, SpeedskatingPulserend elektrostatisch veld,Pulsating electrostatic field (PESF)
Registration Number
NL-OMON22212
Lead Sponsor
Sponsor Ziekenhuis TjongerschansSponsor GLNP life sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

Age 18 years or older.

Skating at a regional and/or national level.

Exclusion Criteria

Presence of implanted electronic devices (pacemaker).

Injuries whereby training and competition are different from normal.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To analyse the effect of six weeks PESF treatment on aerobic and anaerobic performance, measured with an maximum exercise test on the bicycle ergometer (VO2max and Wingate 30) in speedskaters aged between 18-23.
Secondary Outcome Measures
NameTimeMethod
To analyse the effect of PESF on:<br /><br>· personal best times in a speedskating competition after four weeks.<br /><br>· quality of life measured by the RAND-36 questionnaire after six weeks of treatment.<br /><br>· fatigue (locally in the lower extremity and general) measured by an adapted visual analogue scale during the six weeks of treatment with PESF.
© Copyright 2025. All Rights Reserved by MedPath